|
laricitrin 5'-O-methyltransferase activity
|
GO_0070448 |
[Catalysis of the reaction: S-adenosyl-L-methionine + laricitrin = S-adenosyl-L-homocysteine + syringetin.] |
|
elongin complex
|
GO_0070449 |
[A transcription elongation factor complex that suppresses RNA polymerase II pausing, and may act by promoting proper alignment of the 3'-end of nascent transcripts with the polymerase catalytic site. Consists of a transcriptionally active Elongin A subunit (about 100 kDa) and two smaller Elongin B (about 18 kDa) and Elongin C (about 15 kDa) subunits.] |
|
R8 cell-mediated photoreceptor organization
|
GO_0045470 |
[The regionalization process that coordinates the recruitment and organization of other non-R8 photoreceptors by the R8 photoreceptor.] |
|
response to ethanol
|
GO_0045471 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.] |
|
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
|
GO_0070430 |
[Any process that activates or increases the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 1 (NOD1) pathway.] |
|
positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
|
GO_0070426 |
[Any process that activates or increases the frequency, rate, or extent of a nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (NLR) pathway.] |
|
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
|
GO_0070428 |
[Any process that modulates the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 1 (NOD1) pathway.] |
|
nucleotide-binding oligomerization domain containing 2 signaling pathway
|
GO_0070431 |
[The series of molecular signals initiated by the binding of a ligand (such as a bacterial peptidoglycan) to a cytoplasmic nucleotide-binding oligomerization domain containing 2 (NOD2) protein receptor, and ending with regulation of a downstream cellular process.] |
|
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
|
GO_0035872 |
[The series of molecular signals initiated by a ligand binding to a nucleotide-binding domain, leucine rich repeat containing receptor (NLR), and ending with the regulation of a downstream cellular process. NLRs are cytoplasmic receptors defined by their tripartite domain architecture that contains: a variable C-terminus, a middle nucleotide-binding domain, and a LRR domain that is variable in the repeats composition and number.] |
|
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
|
GO_0070432 |
[Any process that modulates the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway.] |
|
regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
|
GO_0070424 |
[Any process that modulates the frequency, rate, or extent of a nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (NLR) pathway.] |
|
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
|
GO_0070433 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway.] |
|
negative regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
|
GO_0070425 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of a nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (NLR) pathway.] |
|
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
|
GO_0070434 |
[Any process that activates or increases the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway.] |
|
Shc-EGFR complex
|
GO_0070435 |
[A protein complex that contains the epidermal growth factor receptor (EGFR) and the adaptor protein Shc, and is involved in linking EGFR activation to the p21-Ras pathway.] |
|
Grb2-EGFR complex
|
GO_0070436 |
[A protein complex that contains the epidermal growth factor receptor (EGFR) and Grb2, and is involved in linking EGFR activation to the p21-Ras pathway.] |
|
Grb2-Shc complex
|
GO_0070437 |
[A protein complex that contains Grb2 and the adaptor protein Shc, and is involved in linking epidermal growth factor receptor (EGFR) activation to the p21-Ras pathway.] |
|
obsolete mTOR-FKBP12-rapamycin complex
|
GO_0070438 |
[OBSOLETE. A protein complex that contains the mTOR (mammalian target of rapamycin) serine/threonine kinase, the peptidyl-prolyl cis-trans isomerase FKBP12 (FKBP1A) and rapamycin (sirolimus).] |
|
Mad-Max-mSin3A complex
|
GO_0070439 |
[A transcriptional repressor complex that contains a heterodimer of the bHLH-ZIP proteins Mad and Max, plus mSin3A, a homolog of the yeast Sin3p.] |
|
pole plasm
|
GO_0045495 |
[Differentiated cytoplasm associated with a pole (animal, vegetal, anterior, or posterior) of an oocyte, egg or early embryo.] |